CD4 T suppressor cells mediate interferon tau protection against experimental allergic encephalomyelitis

Journal of Neuroimmunology

Volumn 75, Issue 1-2, 1997, Pages 35-42

  Mujtaba, Mustafa G ^a   Soos, Jeanne M ^a,b   Johnson, Howard M ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

experimental allergic encephalomyelitis; interferon tau; interleukin 10; myelin basic protein; suppressor cells; transforming growth factor

Indexed keywords

BETA INTERFERON; INTERLEUKIN 10; MYELIN BASIC PROTEIN; SUPPRESSOR FACTOR; TAU INTERFERON; TRANSFORMING GROWTH FACTOR BETA;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; SUPPRESSOR CELL; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; CATTLE; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERFERON TYPE I; INTERFERON TYPE II; INTERLEUKIN-10; MICE; MICE, INBRED STRAINS; MYELIN BASIC PROTEINS; PREGNANCY PROTEINS; SHEEP; SPLEEN; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY; TRANSFORMING GROWTH FACTOR BETA;

EID: 0030894174     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(96)00231-7     Document Type: Article

References (22)

1. Blank, M., Krause, I., Buskila, D., Teitelbaum, D., Kopolovic, J., Afek, A., Goldberg, I. and Shoenfeld, Y. (1995) Bromocriptine immuno-modulation of experimental SLE and primary antiphospholipid syndrome via induction of nonspecific T suppressor cells. Cell. Immunol. 162, 114-122.
2. + antiergotypic cells in Lewis rats. J. Exp. Med. 177, 881-889.
3. Chaouat, G., Assal-Meliani, A., Martal, J., Raghupathy, R., Elliot, J., Mosmann, T. and Wegmann, T.G. (1995) IL 10 prevents naturally occurring fetal loss in the CBA X DBA/2 mating combinations, and local defect in IL10 production in this abortion-prone combination is corrected by in vivo injection of IFNτ. J. Immunol. 154, 4261-4268.
4. Fleischmann, W.R., Koren, S. and Fleischmann, C.M. (1992) Orally administered interferons exert their white blood cell suppressive effects via a novel mechanism. Proc. Soc. Exp. Bio. Med. 201, 200-207.
5. Heeke, G.V., Ott, T.L., Strauss, A., Ammaturo, D. and Bazer, F.W. (1996) High yield expression and secretion of the ovine pregnancy recognition hormone interferon-tau by Pichia pastoris. J. Interferon Res. 16, 119-126.
6. Johns, L.T., Flanders, K.C., Ranges, G.E. and Sriram, S. (1991) Successful treatment of experimental allergic encephalomyelitis with transforming growth factor-β1. J. Immunol. 147, 1792-1796.
7. Johnson, H.M. and Blalock, J.E. (1980) Interferon immunosuppression: Mediation by a suppressor factor. Infect. Immun. 29, 301-305.
8. + suppressor cells inhibit the function of effector cells of experimental autoimmune encephalomyelitis through a mechanism involving transforming growth factor-beta. J. Immunol. 146, 1163-1168.
9. Kumar, V. and Sercarz, E. (1994) Holes in the T cell repertoire to myelin basic protein owing to the absence of the D beta 2-j beta 2 gene cluster: Implications for T cell receptor recognition and autoimmunity. J. Exp. Med. 179, 1637-1643.
10. Martinotti, A., Stoppacciaro, A., Vagliani, M., Melani, C., Spreafico, F., Wysocka, M., Parmiani, G., Trinchieri, G. and Colombo, M.P. (1995) CD4 T cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 genes. Eur. J. Immunol. 25, 137-146.
11. + suppressively regulatory T lymphocytes which down-regulates experimental autoimmune orchitis (EAO) in mice. Clin. Exp. Immunol. 96, 138-145.
12. Nabozny, G.H., Cobbold, S.P., Waldmann, H. and Kong, Y.L. (1991) Suppression in murine experimental autoimmune thyroiditis: In vivo inhibition of CD4+ T cell-mediated resistance by a nondepleting rat CD4 monoclonal antibody. Cell. Immunol. 138, 185-196.
13. Nouri, A.K.T., Lombard, M. and Williams, R. (1991) High serum levels of CD8 antigen in primary biliary cirrhosis: A possible cause of suppressor cell dysfunction. Clin. Exp. Immunol. 86, 140-144.
14. Pontzer, C.H., Bazer, F.W. and Johnson, H.M. (1991) Antiproliferative activity of a pregnancy recognition hormone, ovine trophoblast protein-1. Cancer Res. 51, 5304-5307.
15. Rott, O., Fleischer, B. and Cash, E. (1994) Interleukin-10 prevents experimental allergic encephalomyelitis in rats. Eur. J. Immunol. 24, 1434-1440.
16. Schluesener, H.J. and Lider, O. (1989) Transforming growth factors β1 and β2: Cytokines with identical immunosuppressive effects and potential role in the regulation of autoimmune T cell function. J. Neuroimmunol. 24, 249-258.
17. Smith, H., Sakamoto, Y., Kasai, K. and Tung, K.S. (1991) Effector and regulatory cells in autoimmune oophoritis elicited by neonatal thymectomy. J. Immunol. 147, 2928-2933.
18. Soos, J.M., Subramaniam, P.S., Hobeika, A.C., Schiffenbauer, J. and Johnson, H.M. (1995) The IFN pregnancy recognition hormone, interferon tau, blocks both development and superantigen reactivation of experimental allergic encephalomyelitis without associated toxicity. J. Immunol. 155, 2747-2753.
19. Soos, J.M., Mujtaba, M.G., Subramaniam, P.S., Streit, W.J. and Johnson, H.M. (1997) Oral feeding of interferon τ can prevent the acute and chronic relapsing forms of experimental allergic encephalomyelitis. J. Neuroimmunol. 75, 43-50.
20. Stevens, D.B., Gould, K.E. and Swanborg, R.H. (1994) Transforming growth factor-beta 1 inhibits tumor necrosis factor-alpha/lymphotoxin production and adoptive transfer of disease by effector cells of autoimmune encephalomyelitis. J. Neuroimmunol. 51, 77-83.
21. Zamvil, S.S. and Steinman, L. (1990) The T lymphocyte in experimental allergic encephalomyelitis. Annu. Rev. Immunol. 8, 579-621.
22. Zamvil, S.S., Al-Sabboagh, A., Nelson, P.A., Kaul, D., Charles, M.S., Mitchell, D.J., Steinman, L., Weiner, H.L. and Kuchroo, V.K. 1994. 'Lupus-prone' mice are susceptible to organ-specific autoimmune disease, experimental allergic encephalomyelitis. Pathobiology 62, 113-119.